Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HMGCR | P04035 | 6/20 | 0.48 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.48 |
| ▸ | SIRT6 | Q8N6T7 | 2/20 | 0.48 |
| ▸ | ABCC3 | O15438 | 1/20 | 0.48 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.48 |
| ▸ | PGR | P06401 | 1/20 | 0.48 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.48 |
| ▸ | RXRA | P19793 | 1/20 | 0.48 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.48 |
| ▸ | CCKAR | P32238 | 1/20 | 0.48 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.48 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.48 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.48 |
| ▸ | SLC10A1 | Q14973 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6493211 | 1.00 | HMGCR (0.48) | HMGCRCYP2C9SIRT6ABCC3ABCB11 | |
| SCHEMBL6491097 | 1.00 | HMGCR (0.48) | HMGCRCYP2C9SIRT6ABCC3ABCB11 | |
| SCHEMBL6491095 | 1.00 | HMGCR (0.48) | HMGCRCYP2C9SIRT6ABCC3ABCB11 | |
| SCHEMBL5731382 | 0.88 | HMGCR (0.43) | HMGCRABCC3ABCB11 | |
| SCHEMBL5731375 | 0.88 | HMGCR (0.43) | HMGCRABCC3ABCB11 | |
| SCHEMBL5731656 | 0.85 | HMGCR (0.59) | HMGCRCYP2C9SIRT6ABCC3ABCB11 | |
| SCHEMBL5731642 | 0.85 | HMGCR (0.59) | HMGCRCYP2C9SIRT6ABCC3ABCB11 | |
| SCHEMBL5731660 | 0.85 | HMGCR (0.59) | HMGCRCYP2C9SIRT6ABCC3ABCB11 | |
| SCHEMBL5731645 | 0.85 | HMGCR (0.59) | HMGCRCYP2C9SIRT6ABCC3ABCB11 | |
| SCHEMBL6493160 | 0.83 | HMGCR (0.61) | HMGCRABCB11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050154042-A1 | N-alkyl pyrroles as HMG-CoA reductase inhibitors | WARNER-LAMBERT COMPANY | 2005-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050154042-A1 | N-alkyl pyrroles as HMG-CoA reductase inhibitors | HMGCR, DHCR7, CYP11A1 | HMGCR 1/4885CYP2C9 554/4885SIRT6 761/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.